DayQuil Medicines with DXM

Case Name
Clay et al. v. The Procter & Gamble Co.
21-cv-11133, S.D.N.Y.
(Dec. 2021)
Product/Service DayQuil medicines containing dextromethorphan hydrobromide (DXM)
Allegations Misleadingly marketing medicines as “non-drowsy” when an ingredient in them causes drowsiness
Status Pending
Print Friendly, PDF & Email


Leave a Reply

Back to Top ↑
  • Search Class-Action Tracker

  • Recent Class Actions

  • The Class-Action Tracker is intended to notify consumers about false advertising class-action lawsuits filed around the country, but does not necessarily reflect’s opinion with respect to the lawsuits or disposition of the cases